Table of Content

01 July 2022, Volume 40 Issue 13

Previous Issue    Next Issue

The Influencing Factors of Bone Mineral Density Reduction in the Elderly Population in Health Check-up Center

MA Li, WANG Fang, TIAN Hai-ning

2022, 40(13):  1-4. 

Asbtract ( 150 )   PDF (2029KB) ( 36 )  

References | Related Articles | Metrics

Objective To investigate the incidence of bone mineral density reduction in elderly people （age>65 years old） in the health examination center of Huantai County People’s Hospital, and to explore the related influencing factors. Methods A retrospective analysis was performed on the elderly population who had undergone physical examination at the Physical Examination Center of Huantai County People’s Hospital from January, 2020 to July, 2021. Among them, 657 people who had undergone bone mineral density measurement were selected and divided into two groups according to whether bone mineral density decreased. In the two groups （292 people in the normal BMD group and 365 people in the reduced BMD group）, general information was investigated using self-designed questionnaires. Logistic regression was used to analyze the influence of smoking, body mass index, blood pressure, outdoor sports and other factors on bone mineral density. Results There was no statistical significant difference in age, gender, LDL and diabetes prevalence between the two groups(P>0.05). The body mass index （BMI） of the reduced BMD group was significantly lower than that of the normal BMD group, and the normal BMD group was higher The prevalence of blood pressure was lower than that in the decreased bone mineral density group （P<0.05）. Logistic regression showed that BMI, prevalence of hypertension, smoking, and frequent participation in outdoor sports were the influencing factors of bone mineral density reduction, with OR values of -0.819, 3.772, 1.874, and -1.592, respectively. Conclusion The incidence of bone mineral density reduction in the elderly physical examination population in Huantai area health examination center is about 44.44%. Hypertension and smoking are risk factors for the trend of bone mineral density reduction. BMI and frequent participation in outdoor sports are independent protective factors of bone mineral density.

Clinical Observation of Guizhi Fuling Xiaozheng Decoction Combined with Western Medicine in the Treatment of Undamaged Ectopic Pregnancy

ZHOU Yun-li, Feng Lin

2022, 40(13):  4-7. 

Asbtract ( 179 )   PDF (2076KB) ( 68 )  

References | Related Articles | Metrics

Objective To observe the clinical efficacy of Guizhi Fuling Xiaozheng decoction combined with western medicine methotrexate and mifepristone in the treatment of undamaged ectopic pregnancy. Method 96 patients with intact ectopic pregnancy in Qujing maternal and child health hospital from January 2021 to October 2021 were randomly divided into treatment group and control group; The control group was treated with methotrexate and mifepristone, and the treatment group was treated with methotrexate and mifepristone combined with Guizhi Fuling Xiaozheng decoction.The therapeutic dffects of the two groups were compared. Result The total effective rate in the treatment group was significantly higher than in the control group (P<0.05) β- Time and blood when hCG decreased more than 1/2 β- The time of hCG turning negative, the time of absorption reduction of ectopic pregnancy mass more than 1/2 and the time of hospitalization in the control group were shorter than those in the control group (P<0.05). Conclusion Guizhi Fuling Xiaozheng decoction combined with western medicine methotrexate and mifepristone has a significant clinical effect in the treatment of unruptured ectopic pregnancy and can significantly reduce blood pressure β- HCG value, accelerate the absorption of ectopic pregnancy mass, quickly improve clinical symptoms, improve clinical cure rate, shorten the course of disease, and reduce the tadverse effects of drugs.

Observation on the Therapeutic Value of Rivastigmine Bitartrate Capsules Combined with Selegiline in the Treatment of Parkinson’s Disease

WANG An-ying, LU Dian-ping

2022, 40(13):  8-11. 

Asbtract ( 203 )   PDF (2059KB) ( 15 )  

References | Related Articles | Metrics

Objective To explore the value of the treatment and application of rivastigmine bitartrate capsules combined with selegiline in the treatment of Parkinson’s disease. Methods A total of 80 patients with Parkinson’s disease who were admitted to the Department of Neurology of Goerroth Mongolian Autonomous County Hospital from October 2020 to September 2021 were selected as the research subjects. According to the random number table method, they were divided into control group and study group, with 40 patients in each group. Control group was given selegiline treatment, study group was given carbalatin ditartrate capsule combined selegiline treatment, treatment effect, adverse reactions, IGF-1 （insulin growth factor） and Aβ1-42 （human β -amyloid polypeptide 1-42）, quality of life, cognitive function after treatment,score of Parkinson’s disease in 2 groups were compared. Results After treatment, IGF-1 and Aβ1-42 in study group were higher than those in control group, and the difference was statistically significant （P<0.05）. There was no significant difference in the incidence of adverse reactions between 2 groups （P>0.05）. The therapeutic effect of the study group was higher than that of the control group, and the difference was statistically significant （P<0.05）. After treatment, the SF-36 score of patients in the study group was higher than that in the control group, the difference was statistically significant （P<0.05）; The cognitive function of the study group was higher than that of the control group, and the difference was statistically significant （P<0.05）. Before treatment, there was no significant difference in the comprehensive score of Parkinson’s disease between study group and control group （P>0.05）. After treatment, the comprehensive score of Parkinson’s disease in study group was lower than that in control group, and the difference was statistically significant （P<0.05）. Conclusion Rivastigmine Bitartrate Capsules combined with selegiline in the treatment of Parkinson’s disease can acan adjust the relevant serological indicators of patients, improve the quality of life and cognitive function of patients, improve the therapeutic effect, worthy of clinical application.

Visual Analysis of Research Hotspots of Domestic and International Ehealth Literacy Based on CiteSpace

YU Jia-wei, SUN Yu-jing, REN Jing-jing, LIU Ying

2022, 40(13):  11-15. 

Asbtract ( 1068 )   PDF (2504KB) ( 38 )  

References | Related Articles | Metrics

Objective To provide a reference for the research on improving eHealth Literacy of different stages of population in china, by analyzing and comparing the research hotspots of eHealth Literacy at domestic and international. Methods The CNKI and Web of Science core collection databases were selected to retrieve the literature published from January 1999 to December 2021, the total 698 literatures were analysed by Citespace visual analysis. Results In this study. The number of foreign publications was generally on the rise, research hotspots of eHealth Literacy were theoretical research, influencing factors, access channels, and access capabilities, as well as eHealth assessment and application, health interventions for chronic diseases, public health care, etc. However, the number of articles published in China is still in its initial stage, showing a slow upward trend. Domestic research institutions lacked cooperation, while the research of eHealth Literacy focused on theoretical models, influencing factors, measurement and application, and health interventions, and other aspects. Conclusion The research on e-health literacy in Chima and abroad is in its infancy, and more exploration and development will be needed in the future.

Value Analysis of the Effect of Standardized Treatment of Gestational Diabetesmellitus on Pregnancy Outcomes

SHEN Xue

2022, 40(13):  16-19. 

Asbtract ( 128 )   PDF (2028KB) ( 39 )  

References | Related Articles | Metrics

Objective To observe the clinical effect of standardized treatment in the treatment of patients with gestational diabetes mellitus,and to explore its influence on the pregnancy outcome of the patients. Methods A total of 114 patients with gestational diabetes mellitus admitted to the Department of Obstetrics, Pingyi Hospital of Traditional Chinese Medicine from February 2020 to January 2021 were selected as the research subjects, and were divided into control group and standard group according to random number table method, with 57 patients in each group. The control group was treated with routine treatment, and the standard group was treated with standardized treatment. Blood glucose index, fasting insulin （FINS）, insulin resistance index （HOMA-IR）, islet β cell function index （HOMA-β）, natural delivery rate and the incidence of adverse events in delivery and Perinatal infant were observed and compared between the two groups before and after treatment. Results The fasting blood glucose （FPG）,2 h postprandial blood glucose （2 hPG）,and glycosylated hemoglobin （HbA_1c） indexes of the patients in the standard group after treatment were significantly lower than those in the control group,and the differences were statistically significant （P<0.05）; HOMA-β in the standard group was higher than that in the control group, the difference was statistically significant （P<0.05）; The natural childbirth rate in standard group was significantly higher than that in control group, and the difference was statistically significant （P<0.05）; The incidence of adverse birth events and perinatal events in normative group were lower than those in control group, with statistical significance （P<0.05）. Conclusions tandardized treatment of gestational diabetes mellitus is very effective and can improve the pregnancy outcome of patients.It deservesclinical application.

Effects of PDCA Management on Complications after Injection of Iodine Contrast Agent Extravasation in CT Enhanced Scanning

LIU Qing, LIU Linlin, LIN Juan, JIANG Hong, ZHOU Lijin, WANG Min

2022, 40(13):  19-21. 

Asbtract ( 240 )   PDF (2085KB) ( 42 )  

References | Related Articles | Metrics

Objective To explore the effect of plan do check act （PDCA） management on reducing the complications after iodine contrast agent extravasation in CT enhanced scanning. Methods 220 patients with peripheral venous catheterization injected with iodine contrast agent in CT enhanced scanning at Department of Radiology, Shanghai Tongren Hospital from June 2020 to June 2021 were selected and randomly divided into control group and experimental group. Each group contained 110 patients. Routine nursing management was implemented in the control group and PDCA management was carried out in the experimental group. The leakage rate of iodine contrast agent, leakage volume, adverse reaction and patient satisfaction were compared between the two groups. Results The leakage rate and volume of the experimental group were significantly lower than those of the control group. And the leakage of the experimental group was mainly mild, while there were a large number of moderate and severe cases in the control group. The difference was statistically significant （P<0.05）. The incidence of adverse reactions after extravasation of iodine contrast agent in the experimental group was significantly lower than that in the control group （P<0.05）. The patient satisfaction in the experimental group was higher than that in the control group, which showed significant difference in statistics （P<0.05）. Conclusions PDCA management showed significant effects on reducing the complications after iodine contrast agent extravasation in CT enhanced scanning. It can effectively reduce the incidence of adverse reactions after iodine contrast agent extravasation and r the amount of leakage, so as to ensure the safety of CT enhanced scanning.